Oxford Biomedica PLC

Director's Dealing • May 3, 2013

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9987D

Oxford Biomedica PLC

03 May 2013

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

1	Issuer	Oxford BioMedica PLC
2	Reason for notification	Notification relates to DTR 3.1.2R
3	Name of PDMR	Martin Diggle
4	Connected person	Notification relates to following connected persons: Vulpes Testudo Fund Vulpes Life Sciences Fund
5	Notification in respect of	Notification in respect of holdings of persons in 4 above
6	Description of shares	Oxford BioMedica PLC ordinary shares of 1p each
7	Name of registered shareholders and number of shares	Vulpes Testudo Fund - 2,942,339 shares Vulpes Life Sciences Fund - 364,000,000 shares
8	Nature of transaction	Purchase
9	Number of shares acquired	Vulpes Testudo Fund - 2,942,339 shares Vulpes Life Sciences Fund - 2,170,589 shares
10	Percentage of issued class acquired	Vulpes Testudo Fund - 0.21% Vulpes Life Sciences Fund - 0.15%
11	Shares disposed	N/A
12	Percentage of issued class disposed	N/A
13/14	Price per share of transactions, and date	Vulpes Testudo Fund 2,328,178 shares @ £0.0197, 1 May 2013 614,161 shares @ £0.02 , 2 May 2013 Vulpes Life Sciences Fund 2,170,589 shares @ £0.0197, 1 May 2013
15	Total holding following notification and total percentage holding following notification	Vulpes Testudo Fund - 2,942,339 shares Vulpes Life Sciences Fund - 364,000,000 shares 26.06%
16	Date issuer informed	3 May 2013
23	Any additional information	None
24	Contact name and telephone number	T. Watts, Chief Financial Officer Oxford BioMedica +44 (0)1865 783000

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSBDGDUGDGBGXX